Accelevir Diagnostics is a growing Maryland biotechnology company creating innovative assays for ultra-rare analytes in infectious disease and beyond. With expertise spanning virology, immunology, genomics and cell and gene therapy, our team develops, scales, and commercializes complex assay workflows to support our biopharma partners from basic research through clinical trials.
We are currently focused on advancing new assays for persistent HIV-1 and other clinically important viral infections. To date, we have received over $15M in federal, state and private funding to advance our assays. We are actively working with leading academic and bio-pharma groups to provide our assays in support of translational research and early-stage clinical trials aimed at developing game-changing therapeutics with the potential to cure chronic viral infections.
Company Details
- Employees
- 10
- Address
- 701 E Pratt St, Baltimore,maryland 21202,united States
- in****@****vir.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- accelevirdx.com
- Keywords
- HIV/AIDS, Virology, Genomics, Immunology, Digital PCR, CRO Assay Services, Assay Validation/Verification.
- HQ
- Baltimore, Maryland
Accelevir Diagnostics Questions
Accelevir Diagnostics's website is accelevirdx.com
Accelevir Diagnostics's LinkedIn profile is https://www.linkedin.com/company/accelevirdx
Accelevir Diagnostics has
10 employees.
View email and phone details for 10
employees at Accelevir Diagnostics.
Accelevir Diagnostics's industry is
Biotechnology Research
Accelevir Diagnostics's top competitors are
Cdi Labs,
Flavocure Biotech, Inc.,
Cerillo,
Thermo Fisher Scientific,
Noble Life Sciences Inc,
Cartesian Therapeutics,
Astrazeneca,
Elixirgen Therapeutics, Inc.,
The Henry M. Jackson Foundation For The Advancement Of Military Medicine,
Ricoh Biosciences.
Accelevir Diagnostics's support email address is info@accelevir.com
Accelevir Diagnostics's categories are Biotechnology Research
